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Abstract
Misexpression of Polycomb repressive complex 1 (PRC1) components in human cells profoundly influences the onset of
cellular senescence by modulating transcription of the INK4a tumor suppressor gene. Using tandem affinity purification, we
find that CBX7 and CBX8, two Polycomb (Pc) homologs that repress INK4a, both participate in PRC1-like complexes with at
least two Posterior sex combs (Psc) proteins, MEL18 and BMI1. Each complex contains a single representative of the Pc and
Psc families. In primary human fibroblasts, CBX7, CBX8, MEL18 and BMI1 are present at the INK4a locus and shRNA-mediated
knockdown of any one of these components results in de-repression of INK4a and proliferative arrest. Sequential chromatin
immunoprecipitation (ChIP) reveals that CBX7 and CBX8 bind simultaneously to the same region of chromatin and
knockdown of one of the Pc or Psc proteins results in release of the other, suggesting that the binding of PRC1 complexes is
interdependent. Our findings provide the first evidence that a single gene can be regulated by several distinct PRC1
complexes and raise important questions about their configuration and relative functions.
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Introduction
Polycomb Group (PcG) proteins, so named because of
mutations that affect the patterning of the male sex combs in
Drosophila, are transcriptional repressors that participate in distinct
multiprotein complexes, the best characterized being Polycomb
repressive complexes 1 and 2 (PRC1 and PRC2) [1,2]. The PRC2
complex has three core components and catalyzes the trimethyla-
tion of histone H3 at lysine 27 (H3K27me3) [3] whereas the
prototypic PRC1 complex comprises stoichiometric amounts of
Polycomb (Pc), Posterior sex comb (Psc), Polyhomeotic (Ph) and
Sex combs extra (Sce) [4,5]. PRC1 binds to the H3K27me3 mark
via the chromodomain of the Pc protein [6,7] and catalyzes the
mono-ubiquitylation of histone H2A on lysine 119, thereby
shutting down transcription [8,9] reviewed in ref. [2].
In mammalian cells, the situation is complicated by the presence
of multiple orthologs of the archetypal PRC1 proteins. With five
Pc proteins (CBX2, CBX4, CBX6, CBX7 and CBX8), six Psc
proteins (BMI1, MEL18, MBLR, NSPC1, RNF159 and RNF3),
three Ph proteins (HPH1, HPH2 and HPH3) and two Sce proteins
(RING1 and RING2) there is enormous scope for combinatorial
diversity [10,11]. The reasons for such diversification and the
interplay between the different family members remain unclear.
Genetic ablation of specific PcG genes in mice has confirmed their
role in embryonic patterning and Hox gene regulation but also
pointed to more general effects on stem cell function. For example,
Bmi1 null mice have hematological and neurological defects that
are traceable to a failure in the self-renewal of the relevant stem
cells [12–15]. More recently, genome-wide ChIP analyses have
identified over 1000 genes that are potential targets of PcG-
mediated repression, many of which are implicated in the
maintenance of pluripotency [16–18].
The hematological and neurological defects observed in Bmi1
null mice can be largely rescued by concomitant ablation of the
Ink4a/Arf tumor suppressor locus [12–15]. The locus encodes two
unrelated proteins, p16INK4a and p14ARF (p19Arf in mice), that
activate the retinoblastoma and p53 tumor suppressor pathways,
respectively (reviewed in [10,19]. Both are implicated in cellular
senescence, the state of permanent growth arrest that occurs when
primary cells are exposed to various forms of stress, such as
oncogenic signaling, telomere erosion or oxidative damage.
Curiously, their impact appears to be context dependent with
INK4a playing the predominant role in human cells and Arf
assuming greater significance in mouse cells [10,19].
Two strands of evidence point to an important role for
Polycomb complexes in regulating the locus. Several mouse PcG
gene knockouts have been shown to cause premature senescence
in the derived embryo fibroblasts, due to derepression of Ink4a/Arf
[20–25]. Conversly, ectopic expression of Bmi1, Cbx7, and Cbx8
has been shown to delay senescence in both mouse and human
fibroblasts by downregulating INK4a [26–29]. As part of a broader
effort to characterize the entire range of PRC1 complexes that
regulate INK4a in human cells, we have identified MEL18 as a
direct repressor of the locus in partnership with either CBX7 or
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CBX8. ChIP analyses revealed that CBX7, CBX8, MEL18 and
BMI1 are all present at the promoter and first exon of INK4a, and
shRNA-mediated knockdown of each protein causes upregulation
of p16INK4a. Importantly, we present evidence that these proteins
participate in multiple, distinct PRC1 complexes, that several
PRC1 complexes bind simultaneously to the INK4a locus, and that
their binding appears to be interdependent. To our knowledge,
this is the first indication that PcG-mediated repression requires
cooperation between several distinct types of PRC1 complex.
Materials and Methods
Cell culture, viral transduction and transient transfection
Primary human fibroblasts (FDF and Hs68) and HEK293T
cells were cultured in Dulbecco-modified Eagles medium (DMEM)
supplemented with 10% fetal calf serum (FCS), 100 IU/ml
penicillin, and 100 mg/ml streptomycin. Recombinant lentivirus
and retrovirus vectors (10 mg) were packaged in 293T cells
(3.36106 cells per 10 cm dish) by co-transfection with either 2 mg
of pCG-VsVG and 8 mg pCMVD8.2 [30], or with 2 mg pCG-
VsVG and 8 mg pCG-GagPol [31], using a standard calcium
phosphate based protocol. The following day (17 h post-
transfection) the cells were washed and the medium was reduced
to 5 ml. Virus was harvested 12 h later, filtered through a 45 mm
filter and either used directly or stored at 280uC. Fibroblasts
(86105 cells per 10 cm dish) were infected with 1 ml of virus
diluted 5-fold in complete medium. Retroviruses were used
undiluted. Additional medium was added 8 h later and infected
cells were selected in either puromycin (3 mg/ml), hygromycin B
(25 mg/ml) or blasticidin (2.5 mg/ml) as appropriate. Cells were
generally harvested 14 days post-selection. For co-precipitation
experiments, 293T cells were transfected with a total of 20 mg of
plasmid DNA (10 mg of each construct or empty vector) and cells
were harvested 48 h later.
Cell proliferation assays were performed by staining viable cells
with crystal violet, as previously described [32]. Five days post-
selection, 56103 cells were plated out into each well of a 24-well
plate and 6 wells were used per time point.
Plasmids and shRNAs
pBabePuro-mCbx7-FLAG and pBabeBlast-mCbx8-HA were
generated by cloning the full-length cDNAs of mouse Cbx7 and
Cbx8 in frame with C-terminal FLAG and HA tags, respectively.
The mouse Cbx7 cDNA was also used to construct the mCbx7-
TAP fusion in pcDNA6. Human CBX7-FLAG, CBX7-HA,
CBX8-FLAG and CBX8-HA were expressed from a pcDNA6
based vector (Invitrogen), by sub-cloning the full-length cDNAs of
CBX7 and CBX8 in frame with the C-terminal FLAG or HA
epitope. A similar strategy was used to construct pGM-MEL18-
FLAG. BMI1-FLAG was expressed from a pQCXIP based vector
(Clontech), by sub-cloning the BMI1 coding domain in frame with
the C-terminal FLAG epitope. All plasmids were sequence
verified.
The followingMission shRNA constructs were obtained fromSigma
(BMI1 shRNA1, NM_005180.5-1061s1c1; BMI1 shRNA2, NM_
005180.5-693s1c1; BMI1sh3, NM_0051805-922s51c1; MEL18
shRNA1, NM_007144.2-840s1c1; MEL18 shRNA2, NM_007144.2-
867s1c1; CBX7 shRNA1, NM_175709.1-736s1c1; CBX7 shRNA2,
NM_175709.1-153s1c1; CBX8 shRNA1, NM_020649.1-1183s1c1;
CBX8 shRNA2, NM_020649.1-166s1c1).
Quantitative reverse transcription and PCR
Total RNA was extracted using the Ultra Pure RNA extraction
Kit (Roche). cDNA was generated from 0.5–1 mg of RNA using
MultiScribe reverse transcriptase and random hexamer primers
(Applied Biosystems). One fiftieth of the cDNA was used as a
template for quantitative real-time PCR (q-RTPCR). PCR
products were detected with POWER SybrGreen (Applied
Biosystems). GAPDH was used as a loading control. For detection
of the INK4a transcript, annealing and extension was done for
1 min at 66uC, while for other transcripts this step was performed
at 60uC. Sequences of the primers can be found in Supplementary
Table S1.
Immunoprecipitation and immunoblotting
Cells were washed extensively in phosphate buffered saline
(PBS) and lysed in five cell volumes of IP lysis buffer (1% NP40,
10 mM Tris.HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 30 mM
sodium pyrophosphate, 50 mM sodium fluoride, 10% glycerol,
Complete EDTA free protease inhibitor (Roche) and 1 mM
PMSF) at 4uC. Extracts were centrifuged for 30 min at 4uC and
pre-cleared with Protein G Sepharose. For FLAG-tagged proteins,
extracts were mixed with anti-FLAG M2 coupled agarose (Sigma)
for 3 h, washed extensively in IP lysis buffer and eluted in the same
buffer supplemented with FLAG peptide. Endogenous MEL18
and CBX8 were precipitated with anti-MEL18 (Abcam, ab5267)
bound to Protein G Sepharose (GE Healthcare), or rabbit anti-
CBX8 (GALD, kindly provided by Kristian Helin) [27] bound to
Protein A Sepharose (GE Healthcare).
For total protein analysis, cells were washed in PBS and lysed in
RIPA buffer (20 mM Hepes pH 7.6, 300 mM NaCl, 0.01%
NP40, 1% sodium deoxycholate. 0.1% sodium dodecyl sulphate
(SDS), 2 mM EDTA, Complete EDTA free protease inhibitor
(Roche), and 1 mM PMSF). Samples (25 mg) of total protein were
separated by SDS-polyacrylamide gel electrophoresis gel (PAGE)
in a 12% gel and transferred onto a nitrocellulose membrane. The
following primary antibodies were used: mouse anti-BMI1
(ab14389, Abcam), goat anti-MEL18 (ab5267, Abcam), rabbit
anti-CBX8 (Bethyl Laboratories), rabbit anti-CBX7 (ab21873,
Abcam), mouse anti-p16INK4a (JC8), mouse anti-RING2 and
mouse anti-HPH2 (both kindly provided by Haruhiko Koseki),
rabbit anti-b-tubulin (H-235, Santa Cruz) and horse radish
peroxidase (HRP)-conjugated anti-FLAG M2 (Sigma). Donkey
anti-rabbit HRP (GE Healthcare), sheep anti-mouse HRP (GE
Healthcare) and rabbit anti-goat HRP (Dakocytomation) conju-
gated antibodies were diluted 1:2000 and signals were detected by
ECL (GE Healthcare). HRP conjugated anti-GAPDH antibody
(ab9482, Abcam) was used as a loading control.
Chromatin immunoprecipitation
ChIP assays were performed as described previously [33]. For
sequential ChIP experiments, the chromatin was eluted in 1%
SDS, 10 mM EDTA, 50 mM Tris.HCl pH 7.5 for 10 min at
68uC [34]. The eluted chromatin was divided into equal fractions,
diluted 10-fold in dilution buffer (0.01% SDS, 1.1% Triton X-100,
1.2 mM EDTA, 16.7 mM Tris.HCl pH 8.0, 167 mM NaCl) and
the second ChIP was performed as the first step. The CBX8
antibody used for ChIP was raised in rabbits against the synthetic
‘‘LAST’’ peptide [16]. The IgG fraction of the serum was isolated
and further purified against the peptide. Other antibodies were as
follows: rabbit anti-CBX7 (ab21873, Abcam), rabbit anti-MEL18
(Santa Cruz Biotechnology), mouse anti-BMI1 (AF27, kindly
provided by Kristian Helin), mouse anti-GFP (clone 3E1), and
rabbit anti-histone H3K27me3 (Upstate). For sequential ChIP
using FLAG- and HA-tagged mCbx7 and mCbx8, the chromatin
was first enriched by binding of the sonicated chromatin to anti-
FLAG (Sigma) or anti-HA Sepharose beads (Covance). After
extensive washes, the chromatin was eluted with the cognate
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peptide. The eluate was divided in equal fractions, diluted 10-fold
in dilution buffer and the second ChIP was performed as in the
first step. An irrelevant IgG was used as negative control. The
immunoprecipitated DNA was quantified using real-time qPCR
with the primer sets described in reference [35].
Tandem affinity purification of polycomb complexes
A 293T cell line that stably expresses mCbx7-TAP was
produced by transfection of AhdI linearized pcDNA6-mCbx7-
cTAP using Lipofectamine 2000 (Invitrogen). After 48 h, the cells
were trypsinized and plated at several dilutions in medium
containing blasticidin (10 mg/ml). Single colonies were picked 20 d
later. A single clone was selected in which the expression level was
moderate and uniform within the clone, as determined by
immunofluorescence. 293T derived cell lines that stably express
MEL18-TAP or BMI1-TAP were described previously [36].
Purification of mCbx7-TAP followed the same protocol except
that ZnCl2 was omitted from the buffers, NaCl was at a
concentration of 150 mM and TEV cleavage was conducted at
4uC overnight. Following separation of the proteins on 4–12% Bis-
Tris Novex gel (Invitrogen) in MOPS buffer, the gel was stained
with Colloidal Blue (Sigma). Visible bands were excised and
subjected to trypsin digestion in gel and liquid chromatography-
tandem mass spectrometry (LC-MS/MS). Only those protein
identified with Mascot scores above a cut-off value of 50 were
considered potential partners of mCbx7.
Results
Human PRC1 complexes contain single representatives
of the Pc and Psc families
A PRC1 type complex containing CBX8 has been shown to act
as a repressor of INK4a transcription in human fibroblasts [27].
Purification and characterization of this complex revealed a
number of other PRC1 components, notably the Psc homolog
BMI1 and both Sce proteins (RING1 and RING2), but no other
member of the Pc family was reported to be present. However, we
and others have shown that another Pc homolog, CBX7, also
associates with and represses INK4a [10,37,38]. With the aim of
identifying the PcG proteins that functionally associate with
CBX7, we performed tandem affinity purification of complexes
based on mouse Cbx7 (mCbx7), because of its relative stability, as
well as human BMI1 and the closely related Psc protein MEL18.
In each case, the bait protein was tagged at its carboxy terminus
with the classical TAP motif, comprising elements of calmodulin
binding protein and protein A separated by a TEV cleavage site
[39]. Purification was performed using HEK293T cells that were
stably transfected with the relevant vectors. Purified complexes
were fractionated by SDS-PAGE and following Coomassie
staining of the gel (Supplementary Fig. S1), the bands were
excised and subjected to trypsin digestion and mass spectrometric
analyses. In each case, a parallel analysis was performed on
equivalent bands from a TAP-only control. Functional appraisal of
the BMI1 and MEL18 complexes has already been reported [36].
As summarized in Supplementary Figure S1, we did not detect
other Pc proteins in the mCbx7 complex and found no evidence
that other Psc proteins co-purified with either BMI1 or MEL18, in
agreement with recently published findings from other groups
[27,40].
As these conclusions relied on the absence of identifiable
peptides in mass spectrometry analyses, we substantiated them in a
number of ways. For example, when HA-tagged versions of
human CBX7 and CBX8 were transiently expressed in 293T cells
along with FLAG-tagged Psc proteins, it was possible to co-
precipitate HA-CBX7 and HA-CBX8 with either FLAG-BMI1 or
FLAG-MEL18 (Fig. 1A). However, when FLAG-tagged CBX7
was co-expressed with HA-tagged CBX8, there was no evidence
for an interaction between these proteins and a similar result was
obtained when the epitope tags were exchanged (Fig. 1B).
Importantly, immunoprecipitation of endogenous MEL18 from
293T cells confirmed its interaction with CBX8 and lack of
association with BMI1 (Fig. 1C). In a parallel experiment, we
showed that BMI1 and MEL18 can both be co-precipitated with
CBX8 antibodies. Thus far, we have been unable to extend these
analyses to CBX7 because of interference from immunoglobulin
bands on the western blots. Note that RING2 was also co-
precipitated with MEL18 and CBX8 and the mass spectrometry
data suggested that both RING1 and RING2 were present in all of
the affinity purified complexes that we have characterized
(Supplementary Fig. S1). In additional experiments, in which we
conducted affinity purification of MEL18 in cells expressing
FLAG-tagged RING1 and HA-tagged RING2, or vice versa, we
demonstrated unequivocally that RING1 and RING2 are present
in distinct complexes (Supplementary Fig. S2). Taken together,
our data imply that human PcG proteins can participate in
multiple PRC1-type complexes and that each complex contains
single representatives of the Pc, Psc and Sce families.
INK4a is regulated by multiple PRC1 components in
primary HDFs
Minimally, our data suggested that CBX7 and CBX8 form at
least four distinct PRC1-type complexes with MEL18 or BMI1. It
was therefore important to establish which of these combinations
might be implicated in the repression of INK4a in human
fibroblasts. To this end, we first asked whether shRNA-mediated
knockdown of individual PRC1 components affected INK4a
expression. After empirically testing multiple shRNAs against
each target gene, we used lentiviral vectors to express the most
effective hairpins in primary fetal dermal fibroblasts (FDF). The
extent of knockdown was evaluated by qRT-PCR and immuno-
blotting. As exemplified in Figure 2, shRNAs against CBX7,
CBX8, MEL18 or BMI1 each resulted in a significant increase in
p16INK4a expression at both the protein (Fig. 2A) and RNA levels
(Fig. 2B). These effects were consistently observed with indepen-
dent shRNAs but their magnitude varied depending on the strain
of fibroblasts in which the experiments were conducted (Supple-
mentary Fig. S3). As expected from the de-repression of p16INK4a,
knockdown of each of the PRC1 components caused a significant
impairment of cell proliferation culminating in a senescence-like
growth arrest (Fig. 2C). The low levels of p14ARF in primary HDFs
precluded detection by immunoblotting but we did not observe a
consistent change in ARF transcript levels following knockdown of
PRC1 components (see below). At face value, therefore, our data
support the idea that multiple PRC1 components participate in
the repression of INK4a in human fibroblasts.
MEL18 binds directly to the INK4a locus
Although genetic ablation of the mouse Mel18 gene has been
shown to cause premature senescence and de-repression of Ink4a/
Arf [23], there are conflicting views about its role in regulating the
locus [41]. To try to clarify the situation, we performed ChIP
analyses with previously validated primer sets (Fig. 3A and ref.
[35] to establish whether MEL18 interacts directly with the
endogenous human INK4a locus in normal fibroblasts. The pattern
of MEL18 binding was very similar to that described for other
PRC1 components and the H3K27me3 mark, with a peak
centered on the first exon of INK4a and very little binding at the
ARF promoter region (Fig. 3B and C). Specificity was confirmed
Polycomb Regulation of INK4a
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by the fact that shRNA-mediated knockdown of MEL18 caused a
marked reduction in the ChIP signal (Fig. 3B). Interestingly, the
knockdown of MEL18 also resulted in a loss of H3K27me3 across
the first exon of INK4a (Fig. 3C), suggesting that PRC1-type
complexes contribute to the maintenance of the H3K27me3
modification. Alternatively, as components of the PRC2 complex
are regulated by E2F transcription factors [42], loss of H3K27me3
might simply reflect impaired cell proliferation caused by
derepression of INK4a.
Role of BMI1 and MEL18 in mCbx7-mediated repression
of INK4a
As a more cogent test of the functional relevance of each
component, we next asked whether the ability of CBX7 to
downregulate p16INK4a was dependent on either BMI1 or
MEL18. HDFs that had been stably transduced with mCbx7
were superinfected with lentiviral vectors expressing shRNAs
against BMI1 and MEL18. Relative to the GFP control, mCbx7
caused a substantial reduction in p16INK4a RNA and protein
levels, as expected, whereas p14ARF RNA levels were essentially
unchanged (Fig. 4A and 4B). ChIP analyses confirmed that ectopic
mCbx7 caused a substantial increase in CBX7/mCbx7 binding
around the first exon of INK4a, detected using an antibody that
recognizes both the mouse and human versions of the protein,
with little if any change at the ARF promoter (Fig. 4C). This was
accompanied by an increase in the H3K27me3 modification,
particularly at positions coincident with CBX7 (Fig. 4C). Impor-
tantly, shRNA-mediated knockdown of either BMI1 or MEL18
restored p16INK4a levels in the mCbx7-expressing cells, again
without affecting ARF (Fig. 4D and 4E). Moreover, ChIP analyses
revealed that the depletion of BMI1 and MEL18 led to a decrease
in CBX7/mCbx7 binding and H3K27me3 at the INK4a locus
Figure 1. Interaction of CBX7 and CBX8 with BMI1 and MEL18. A. Co- immunoprecipitation of HA-CBX7 and HA-CBX8 with FLAG-BMI1 and
FLAG-MEL18 from transiently transfected 293T cells. Left panels show direct immunoblotting of cell lysates. Right panels show the anti-FLAG
precipitates immunoblotted for the respective FLAG- and HA-tagged proteins. B. Lack of interaction between CBX7 and CBX8 in 293T cells
transfected with the respective HA- and FLAG-tagged proteins. C. Co-immunoprecipitation of endogenous PRC1 components, as indicated, using
polyclonal antibodies against MEL18 and CBX8. Input shows direct immunoblotting of 5% of the sample used for immunoprecipitation.
doi:10.1371/journal.pone.0006380.g001
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(Fig. 4F). These findings suggest that BMI1 and MEL18 are rate
limiting for repression of INK4a by mCbx7.
CBX7 and CBX8 bind simultaneously to the same
segment of the INK4a locus
As we work with pools of cells, the ability of several PRC1
components to modulate INK4a expression is open to different
interpretations. For example, it is conceivable that different PRC1
complexes regulate the locus in different cells or that several PRC1
complexes congregate at the locus in every cell. To try to
distinguish between these possibilities, we set out to determine
whether CBX7 and CBX8 can be detected on the same piece of
DNA, using a ChIP-reChIP strategy. HDFs were co-infected with
retroviruses encoding FLAG-tagged mCbx7 and HA-tagged
mCbx8 to generate pools of drug-resistant cells expressing both
proteins. An initial ChIP was performed using the FLAG antibody
and the chromatin was eluted from the beads with the FLAG
peptide. The recovered chromatin was then immunoprecipitated
with the HA antibody or with an irrelevant IgG and subjected to
qPCR analysis with a subset of the primer sets described in
Figure 3A. The signal was quantified relative to the input material
used in the first ChIP. As illustrated in Figure 5A, mCbx8 was
substantially enriched at the INK4a locus following a mCbx7 ChIP.
In the reciprocal experiment, the chromatin was first precipitated
with the HA antibody and eluted with HA peptide. Again, it was
clear that mCbx7 was enriched in the chromatin precipitated
through mCbx8 (Fig. 5B), implying that mCbx7 and mCbx8 bind
simultaneously to the same fragment of chromatin.
We were conscious that over expression of the mouse Pc
proteins in HDFs could have created an artificial situation. In
order to establish that human CBX7 and CBX8 can co-localize on
INK4a, we performed sequential ChIP targeting the endogenous
proteins. Affinity purified CBX8 antibody was used in the first step
with a non-specific rabbit IgG as a negative control. After elution,
a fraction of the precipitated chromatin was analyzed by
quantitative PCR in order to determine the amount of CBX8
bound to INK4a in the first step (Fig. 5C). The recovered CBX8-
bound chromatin was divided into four equal portions and
immunoprecipitated with antibodies against CBX7, CBX8 and
H3K27me3 or with a non-specific anti-rabbit IgG as a negative
control. Due to the relatively small amounts of chromatin
recovered after the sequential ChIP, the PCR analyses were
restricted to primer pair PS7 which targets the proximal part of the
INK4a exon 1a. Remarkably, the data clearly showed that
endogenous CBX7 can co-precipitate with CBX8 on the same
chromatin fragment (Fig. 5D). As expected, H3K27me3 also co-
Figure 2. INK4a is regulated by multiple PRC1 proteins in human fibroblasts. A. FDF cells were infected with lentiviruses encoding shRNAs
against CBX7, CBX8, BMI1, or MEL18, or an irrelevant control shRNA (C). Effects on the respective target proteins and on p16INK4a were assessed by
immunoblotting with the indicated antibodies. B. Corresponding changes INK4a mRNA were quantified by qRT-PCR. C. Effects of the indicated
shRNAs on cell proliferation was assessed by crystal violet staining. Each time point represents an average of six replicates and the A595nm values were
normalized to the absorbance at day 0 (first day after plating).
doi:10.1371/journal.pone.0006380.g002
Polycomb Regulation of INK4a
PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6380
precipitated with the Pc proteins (Fig. 5D). Taken together, our
data strongly suggest that CBX7 and CBX8, and by implication
distinct PRC1 complexes, can bind simultaneously to the INK4a
locus.
Interdependence between PRC1 complexes for binding
to the INK4a locus
At face value, the sequential ChIP data implied that distinct
PRC1 complexes containing either CBX7 or CBX8 co-localize on
a region of INK4a represented by primer sets 5–9. At the current
level of resolution, it is not possible to judge whether specific
complexes have preferred locations but this seems unlikely given
the potential numbers of PRC1 complexes that might be involved.
However, if all of these complexes are able to regulate the
expression of INK4a, it is unclear why shRNA-mediated ablation
of single components should result in de-repression. A pertinent
observation was that when we knocked down the levels of
endogenous CBX7 with shRNA, this led to a substantial decrease
in the binding of CBX8 at the INK4a locus (Fig. 6A). Conversely,
knockdown of CBX8 resulted in reduced binding of CBX7
(Fig. 6B). Along similar lines, depletion of BMI1 caused a
concomitant loss of MEL18 at the locus and vice versa (Fig. 6C
and D). These effects were not a consequence of cross-talk between
the respective genes. For example, shRNAs against MEL18 had
little if any effects on the expression of BMI1 and likewise
knockdown of BMI1 did not cause significant changes in MEL18
RNA levels (Supplementary Fig. S4). Similar conclusions apply to
CBX7 and CBX8 transcript levels. Interestingly, depletion of any
one of these components resulted in a decline in H3K27me3 at the
INK4a locus (Fig. 6D and E). Taken together, our findings imply
interdependence between the multiple PRC1 complexes that bind
to and regulate the INK4a locus and that the PRC1 complexes
might contribute to the maintenance of the H3K27me3.
Discussion
The data we present provide important and novel insights into
the regulation of INK4a by PcG proteins and suggest a previously
unrecognized level of complexity in PRC1 function. Although it is
widely appreciated that mammalian cells express multiple
orthologs of the prototypic Pc, Psc, Ph and Sce proteins, the
potential for combinatorial specificity has not been properly
addressed [10,43]. There have been several previous descriptions
of mammalian PRC1 complexes as well as of complexes
reconstituted from recombinant proteins [8,9,27,36,40,44–46].
Collectively, these leave open the possibility that, for example,
both RING1 and RING2 may be present in the same complex
and it is clear that some components can oligomerize [47,48]. In
an experiment specifically designed to ask whether RING1 and
RING2 co-purify, we found no evidence that they were present in
the same soluble complex (Supplementary Fig. S2) and our
analyses of several affinity purified complexes and co-immuno-
precipitation data (Fig. 1 and Supplementary Fig. S1) are
consistent with the idea that each PRC1 complex contains a
single representative from the Pc, Psc, Ph and Sce families, in line
with the Drosophila paradigm.
It would be interesting to extend these analyses to obtain a more
comprehensive picture of the possible combinations that exist in
human cells but as proof of principle we focused on four
components for which ChIP grade antibodies are available.
Specifically, we have shown that the Pc homologs CBX7 and
CBX8 can participate in PRC1-type complexes with at least two
representatives of the Psc family, MEL18 and BMI1. All four of
these proteins contribute to the regulation of INK4a as demon-
strated by shRNA-mediated knockdown experiments (Fig. 2 and
Supplementary Fig. S3). For CBX7, CBX8 and BMI1, this is
consistent with published findings [23,27,28] but our study is the
first to compare the different proteins within the same cell system.
In the case of MEL18, there have been conflicting views about its
effects on INK4a and cell proliferation. While many regard MEL18
as a functional analog of BMI1, with overlapping but distinct
activities [23,36,40,49–51], others consider MEL18 as a sequence-
specific DNA binding protein that negatively regulates the
expression of BMI1 through an ability to repress MYC [41,52].
In this scenario, MEL18 and BMI1 are inversely correlated and
have opposing effects on INK4a. While there are precedents for
cross-regulation of PcG genes [16,53] and for a role for MYC in
the regulation of BMI1 [54], these ideas are difficult to reconcile
with the fact that MYC can also activate INK4a in human cells
[55] and that BMI1 and MYC collaborate in tumorigenesis
Figure 3. MEL18 binds directly to the promoter and first exon
of INK4a. A. Schematic of the human INK4a-ARF locus showing the
location of coding exons (black boxes) and transcription start sites, not
drawn to scale. Numbered bars refer to the approximate locations of
primer pairs used for PCR interrogation of precipitated chromatin (as
described in ref. [35]. B. ChIP analyses of MEL18 binding across the
locus in normal fibroblasts (black bars) or in cells that had been
transduced with MEL18 shRNA (grey bars). An irrelevant IgG was used
as a negative control. Results are presented as % of input DNA. C.
Corresponding ChIP data for H3K27me3.
doi:10.1371/journal.pone.0006380.g003
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Figure 4. Involvement of BMI1 and MEL18 in mCbx7-mediated repression of INK4a. A. Immunoblot analyses of FDF cells infected with
retroviruses encoding either mCbx7 or GFP (negative control) showing down-regulation of p16INK4a. B. qRT-PCR analyses of INK4a and ARF RNAs in
cells described in panel A. C. ChIP analyses of CBX7 (mouse+human) and H3K27me3 levels across the INK4a-ARF locus in cells expressing GFP or
mCbx7, using the indicated primer sets (as in Fig. 3). D. The mCbx7 expressing cells were infected with lentivirus-based shRNA vectors targeting
BMI1, MEL18, or an irrelevant control (C). Effects on the respective target proteins and on p16INK4a were assessed by immunoblotting with the
indicated antibodies. GAPDH was used as a loading control. E. qRT-PCR analyses of INK4a and ARF RNAs in cells described in panel D. F. ChIP analyses
of CBX7 (mouse+human) and H3K27me3 in cells expressing shRNAs against BMI1 or MEL18. Anti-rabbit IgG was used as a negative control. The
analyses were confined to primers corresponding to the proximal part of INK4a exon 1a (PS7) and ARF exon 1b (PS2).
doi:10.1371/journal.pone.0006380.g004
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[56,57]. It is possible that different PcG proteins might be rate
limiting in different cell types, or that MEL18 could influence cell
proliferation or differentiation independently of its effects on
INK4a [41,58,59]. However, we find that in primary human
fibroblasts, knockdown of MEL18 with several independent
shRNAs results in de-repression of INK4a and premature
senescence without appreciable changes in BMI1 expression. We
also present compelling evidence that MEL18 binds directly at the
INK4a locus with a similar distribution to that of BMI1 and other
PRC1 proteins.
Genetic ablation of several PcG genes, including Mel18, Bmi1,
Ring1b and Mph2, results in a skeletal transformation and stem cell
defects in mice, and curtailed lifespan in the corresponding MEFs
[20–25]. Although Ink4a expression is clearly deregulated in these
MEFs, Arf plays a more prominent role in senescence in mouse
cells and in some cases the effects of the PcG knockout can be
alleviated by concomitant inactivation of Arf [24,60,61]. In human
cells, however, it is not clear that p14ARF levels are affected by or
contribute significantly to senescence [62,63] and it has proved
difficult to demonstrate that ARF is subject to regulation by PcG
complexes [27,35,64,65]. Consistent with this, we found that the
levels of H3K27me3 at the ARF locus were very low in normal
human fibroblasts and that ARF expression was generally
unaffected by experimental modulation of PRC1 components.
As well as highlighting the role of MEL18, our data imply that
several distinct PRC1 complexes are capable of regulating INK4a.
Moreover, sequential ChIP experiments based on CBX7 and
CBX8 suggest that these complexes are present on the same region
of chromatin. Perhaps the most remarkable aspect of our findings
is that knockdown of any one component caused de-repression of
INK4a and loss of H3K27me3, suggesting some degree of
cooperation or interdependence. While it is feasible that loss of
one component or PRC1 complex could expose the locus to other
influences, such as H3K27 histone demethylase activity, it is not
clear why other complexes are unable to substitute. One possibility
would be that each complex binds at a specific location but this
seems unlikely considering the number of potential permutations
associated with the locus. Within the limited resolution of standard
ChIP protocols, the PRC1 components showed the same relatively
narrow peak of binding around the promoter and first exon of
INK4a, as described in previous studies, with H3K27me3 showing
a broader distribution [27,35,64,65]. A more plausible explanation
would be that the complexes form a higher order structure. This
would explain the pleiotropic effects of individual shRNAs and
Figure 5. CBX7 and CBX8 bind simultaneously to the same INK4a allele. A and B. Sequential ChIP using HDFs that co-express FLAG-tagged
mCbx7 and HA-tagged mCbx8. In A, the first ChIP was performed with the FLAG antibody, followed by either anti-HA or irrelevant IgG. In B, the first
ChIP was performed with the HA antibody, followed by either anti-FLAG or IgG. The precipitated DNA was analyzed by qPCR with the indicated
primer sets. The histograms represent the average and SD values of biological replicates. C and D, Sequential ChIP of endogenous CBX8 and CBX7 in
FDF cells. Chromatin was first precipitated with affinity purified anti-CBX8 antibody and enrichment for INK4a primer set 7 (PS7) was confirmed by q-
PCR. The chromatin was divided into four equal fractions and re-precipitated with either rabbit IgG as a negative control, anti-H3K27me3 or anti-CBX8
as positive controls, or anti-CBX7. The enrichment is calculated relative to the original input chromatin. The figure shows the results of a single
representative experiment.
doi:10.1371/journal.pone.0006380.g005
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why it is difficult to quantify the relative importance of individual
PRC1 proteins.
Although expression profiling and genome wide ChIP on chip
studies have implied that PcG genes may be subject to transcriptional
regulation by PRC1 complexes [16], we did not find consistent
evidence for such effects between the components studied here.
Moreover, the prediction would be that loss of one PcG protein might
enhance the expression of another, the converse of the interdepen-
dence we observe. However, it is clear that their participation in a
higher order structure could present a complicated picture in terms of
the influence of one protein on the stability or post-translational
modification of another. Indeed, we noted that although ectopic
expression of mCbx7 had no effect on BMI1 and MEL18 RNA, there
was a significant increase in the respective protein levels (Fig. 4D).
At this juncture, we have no information on how many
complexes bind to the locus and what sort of higher order
complexes might be involved but there are obvious precedents for
long-range effects and chromosome looping in PcG-mediated
repression [66,67]. An aggregate of PRC1 complexes might be
required to form or stabilize the loop and in principle our data do
not exclude association between different alleles. The ability of
some components to oligomerize, notably the Ph family members
[47,48], could facilitate interactions between neighboring com-
plexes. Alternatively, complexes might be brought together by an
RNA component, and again there are several precedents and
possibilities, including short interfering RNA or antisense non-
coding transcripts [68–72]. Based on current understanding,
PRC1 complexes have the potential to bind to H3K27me3 and
Figure 6. Interdependent binding of PRC1 components at the INK4a locus. ChIP assays were performed in FDF cells infected with lentivirus-
based shRNA vectors targeting CBX8, CBX7, BMI1, MEL18, or an irrelevant control (C) as indicated. The chromatin was precipitated with rabbit
antibodies against CBX8, CBX7, MEL18 and H3K27me3 or with a monoclonal antibody against BMI1. An anti-rabbit IgG was used as a negative
control, except for BMI1 where the control was mouse anti-HA. The precipitated DNA was subjected to qPCR with the indicated primer sets (as
described in Fig. 3) and the data are presented as percentage of input DNA.
doi:10.1371/journal.pone.0006380.g006
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RNA, and to ubiquitylate H2A [6,8,9,36]. However, a require-
ment for several distinct PRC1 complexes in the regulation of
INK4a implies that the complexes might have distinct properties or
functions. In this context, it will be important to establish whether
INK4a represents a special case or whether other PcG target genes
are similarly regulated by multiple types of PRC1 complex.
Supporting Information
Table S1 Table of primers used
Found at: doi:10.1371/journal.pone.0006380.s001 (0.06 MB
DOC)
Figure S1 Analyses of affinity purified PRC1 complexes. A.
SDS-PAGE analyses of proteins that co-purify with TAP tagged
mCbx7, MEL18 or BMI1 from 293T cells. The gels were stained
with Colloidal Coomassie Blue and photographed. Visible bands
were subjected to trypsin digestion and tandem MS/MS analyses.
In each case, control bands were excised from a parallel
purification using the TAP vector alone. The named proteins on
the right of each gel identify known PcG proteins for which
signature peptides were identified by mass spectrometry. B. A
diagrammatic summary of known PcG proteins recovered in each
purification. Note that the circled bait proteins are the only
representatives of their family detected in the respective complex.
Found at: doi:10.1371/journal.pone.0006380.s002 (0.11 MB TIF)
Figure S2 RING1 and RING2 are present in distinct complex-
es. HEK293T cells that stably transduced with TAP-tagged
MEL18 were co-transfected with plasmids encoding FLAG-tagged
RING1 and HA-tagged RING2 (middle panel) or HA-tagged
RING1 and FLAG-tagged RING2 (right panel). The MEL18
complexes were affinity purified according to the schedule on the
left. Following TEV cleavage, to release the complexes from the
IgG beads, the complexes were subjected to a second round of
affinity purification on anti-FLAG beads. This effectively recovers
a complex of MEL18 and one of the FLAG tagged RING
proteins. The recovered material was then eluted with FLAG
peptide, fractionated by SDS-PAGE, and immunoblotted for the
FLAG, HA and CBP epitopes, as indicated. The asterisk in the
right panel indicates a non-specific band which co-purified in this
schedule. Importantly, HA-tagged RING2 did not co-purify with
MEL18 and FLAG-tagged RING2 and likewise, HA-tagged
RING1 did not co-purify with MEL18 and FLAG-tagged RING2.
Found at: doi:10.1371/journal.pone.0006380.s003 (0.08 MB TIF)
Figure S3 Derepression of INK4a with different PcG shRNAs in
different fibroblast strains. The figure shows several experiments
that re-capitulate the effects documented in Figure 2, namely that
shRNA-mediated knockdown of CBX7, CBX8, BMI1 and
MEL18 results in up-regulation of p16INK4a at the protein (left
panels) and RNA levels (right panels). For each PRC1 protein, the
effects could be observed with at least two independent shRNAs
and in several strains of human fibroblast. The data for CBX8,
BMI1 and MEL18 refer to Hs68 cells.
Found at: doi:10.1371/journal.pone.0006380.s004 (0.06 MB TIF)
Figure S4 Lack of cross talk in the regulation of PRC1 gene
expression. A. Knockdown of CBX7 with independent shRNAs
had little if any effect on the expression of CBX8 and vice versa as
assayed by qRT-PCR. B. Similarly, shRNAs against BMI1 had
negligible effects on MEL18 and vice versa. C. In cells over-
expressing mCbx7 (as described in Figure 3), knockdown of BMI1
had no effect on MEL18 and vice versa.
Found at: doi:10.1371/journal.pone.0006380.s005 (0.05 MB TIF)
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